This study revealed a novel non-canonical manner controlling the levels of GLI1 via a menin-mediated epigenetic pathway, and provided a possible mechanism of tumor development of MEN-1 disease, and a rationale for directly inhibiting GLI1 for treating these tumors. Here, GLI1 is linked to neoplasm.